Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction rather than consolidated financial performance.
Material Changes
No material changes to financial performance or operations are reported in this filing. The only reported change is an increase in the American Depositary Shares (ADSs) holdings of Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a transaction where Mr. D E Troy increased his interest in ADSs to 286.233 shares at a price of $46.01 per ADS following the re-investment of the dividend paid on July 5, 2012.
Investor Verification Points
- Verify the total number of ADSs held by Mr. D E Troy post-transaction (286.233).
- Confirm the transaction price of $46.01 per ADS aligns with market prices on July 10, 2012.
- Note that this filing does not contain financial results; refer to the company's Form 20-F or interim reports for financial data.